JP2005506295A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506295A5
JP2005506295A5 JP2002576275A JP2002576275A JP2005506295A5 JP 2005506295 A5 JP2005506295 A5 JP 2005506295A5 JP 2002576275 A JP2002576275 A JP 2002576275A JP 2002576275 A JP2002576275 A JP 2002576275A JP 2005506295 A5 JP2005506295 A5 JP 2005506295A5
Authority
JP
Japan
Prior art keywords
formulas
treatment
compounds
compound
viii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002576275A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506295A (ja
Filing date
Publication date
Priority claimed from US09/792,286 external-priority patent/US7250397B2/en
Priority claimed from PCT/DK2001/000127 external-priority patent/WO2001062775A2/fr
Application filed filed Critical
Priority claimed from PCT/US2002/005773 external-priority patent/WO2002077017A2/fr
Publication of JP2005506295A publication Critical patent/JP2005506295A/ja
Publication of JP2005506295A5 publication Critical patent/JP2005506295A5/ja
Pending legal-status Critical Current

Links

JP2002576275A 2001-02-22 2002-02-22 細胞間連絡促進化合物の新規医薬使用 Pending JP2005506295A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/792,286 US7250397B2 (en) 2000-02-23 2001-02-22 Antiarrhythmic peptides
PCT/DK2001/000127 WO2001062775A2 (fr) 2000-02-23 2001-02-22 Peptides antiarhythmiques
US31447001P 2001-08-23 2001-08-23
PCT/US2002/005773 WO2002077017A2 (fr) 2001-02-22 2002-02-22 Nouvelles utilisations medicales de composes facilitant la communication

Publications (2)

Publication Number Publication Date
JP2005506295A JP2005506295A (ja) 2005-03-03
JP2005506295A5 true JP2005506295A5 (fr) 2006-01-05

Family

ID=27222186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002576275A Pending JP2005506295A (ja) 2001-02-22 2002-02-22 細胞間連絡促進化合物の新規医薬使用

Country Status (6)

Country Link
EP (1) EP1370276B1 (fr)
JP (1) JP2005506295A (fr)
AT (1) ATE497967T1 (fr)
IL (1) IL157447A0 (fr)
MX (1) MXPA03007537A (fr)
WO (1) WO2002077017A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250397B2 (en) 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
EP1469875A1 (fr) 2002-01-29 2004-10-27 Wyeth Compositions et procedes de modulation des demi-canaux de connexines
KR20050086846A (ko) * 2002-11-25 2005-08-30 질랜드 파마 에이/에스 펩티드 간극 결합 조절체
EP1723163A2 (fr) * 2003-12-23 2006-11-22 Wyeth a Corporation of the State of Delaware Modulateurs isopeptidiques de la jonction lacunaire
DE102005005270A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Behandlung leichter bis mittelschwerer Depressionen und Angstzustände
GB0514071D0 (en) 2005-07-07 2005-08-17 Zealand Pharma As N- or C- terminally modified small peptides
WO2007078990A2 (fr) 2005-12-23 2007-07-12 Zealand Pharma A/S Composés modifiés mimétiques de la lysine
DK2468724T3 (en) 2006-12-21 2016-02-22 Zealand Pharma As Synthesis of pyrrolidine compounds
JP2010533690A (ja) * 2007-07-15 2010-10-28 ジーランド・ファーマ・ア／エス ペプチドギャップ結合モジュレーター
WO2010026487A1 (fr) * 2008-09-08 2010-03-11 University Of Concepcion Méthodes et compositions thérapeutiques
GB201512139D0 (en) * 2015-07-10 2015-08-19 Zealand Pharma As Methods of treatment
CN110709096B (zh) 2017-05-05 2023-10-31 泽兰德制药公司 细胞间隙连接通讯调节剂及其在糖尿病性眼病治疗中的应用
WO2021159011A1 (fr) * 2020-02-07 2021-08-12 United States Government As Represented By The Department Of Veterans Affairs Procédé de traitement de lésions du système nerveux avec de la boldine et des analogues de celle-ci
WO2023118366A1 (fr) 2021-12-22 2023-06-29 Breye Therapeutics Aps Modulateurs de jonctions communicantes et leur utilisation pour le traitement de la dégénérescence maculaire liée à l'âge

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19500990A1 (de) * 1995-01-14 1996-07-18 Stefan Dr Med Dhein Neues Peptid, seine Herstellung und Verwendung
DE19707854A1 (de) * 1997-02-27 1998-09-03 Dhein Stefan Priv Doz Dr Med Neue Cyclopeptide, deren Herstellung und Verwendung
ATE284896T1 (de) * 2000-02-23 2005-01-15 Zealand Pharma As Neue antiarrythmische peptide

Similar Documents

Publication Publication Date Title
DK167845B1 (da) Maelke-vaekstfaktor eller et salt deraf, fremgangsmaade til fremstilling deraf, kombinationer deraf med polypeptider samt farmaceutiske og kosmetiske praeparater med indehold deraf
JP2005506295A5 (fr)
JP5607176B2 (ja) 新規ペプチドおよびその用途
US7795222B2 (en) Methods for treating a corneal disorder and promoting skin wound healing
AU2016324119B2 (en) Long-acting adrenomedullin derivative
CN102883736B (zh) 用于促进血管生成的肽及其用途
JP2002206000A (ja) Ｏｂ蛋白組成物を用いる非脂肪組織重増加方法
JP2002542298A (ja) 低分子量トロンビン阻害物質およびそのプロドラッグを含む医薬製剤
US20230295233A1 (en) Polypeptide for repairing mucosal damage or skin wound and use thereof
JPH0242026A (ja) 関節炎の処置
US5700776A (en) Medicaments comprising glicentin as active ingredient
JPH06510754A (ja) 食欲不振および関連症状の治療用のアミリンおよび可能性としてインスリンを含有する組成物
CN102884073B (zh) 用于促进血管生成的肽及其用途
EP4166162A1 (fr) Conjugué acide désoxycholique-peptide à activité anti-obésité et son utilisation
CA2439101A1 (fr) Nouvelles utilisations medicales de composes facilitant la communication
CN114805489A (zh) 一类用于修复皮肤损伤或黏膜损伤的多肽及其应用
CN110372800B (zh) 具有多功能活性的融合多肽及其应用
JP2009191015A (ja) 創傷治癒促進剤
US8476221B2 (en) Methods and compositions for the treatment of metabolic disorders
JP3652865B2 (ja) 乳酸縮合物の混合物及びそれを含有する組成物
CN114106100B (zh) 用于修复皮肤创伤或黏膜损伤的多肽及其应用
WO2022054825A1 (fr) Médicament pour prévenir ou traiter un symptôme ou un trouble chez un sujet affecté par une infection virale
WO2020111743A1 (fr) Peptide, composition et procédé de stimulation d'adipogenèse
CN116003529A (zh) 多肽及其在修复黏膜损伤或皮肤损伤上的应用
RU2071336C1 (ru) Лекарственное средство для наружного применения на основе ткани плаценты